advertisement
Liebmann JM 11
Showing records 1 to 11 | Display all abstracts from Liebmann JM78514 Oral Memantine for the Treatment of Glaucoma: Design and Results of 2 Randomized, Placebo-Controlled, Phase 3 Studies
Weinreb RN
Ophthalmology 2018; 125: 1874-1885
78939 Racial Differences in Rate of Change of Spectral-Domain Optical Coherence Tomography-Measured Minimum Rim Width and Retinal Nerve Fiber Layer Thickness
Bowd C; Zangwill LM
American Journal of Ophthalmology 2018; 196: 154-164
78514 Oral Memantine for the Treatment of Glaucoma: Design and Results of 2 Randomized, Placebo-Controlled, Phase 3 Studies
Liebmann JM; Cioffi GA
Ophthalmology 2018; 125: 1874-1885
78939 Racial Differences in Rate of Change of Spectral-Domain Optical Coherence Tomography-Measured Minimum Rim Width and Retinal Nerve Fiber Layer Thickness
Weinreb RN
American Journal of Ophthalmology 2018; 196: 154-164
78514 Oral Memantine for the Treatment of Glaucoma: Design and Results of 2 Randomized, Placebo-Controlled, Phase 3 Studies
Goldberg I
Ophthalmology 2018; 125: 1874-1885
78939 Racial Differences in Rate of Change of Spectral-Domain Optical Coherence Tomography-Measured Minimum Rim Width and Retinal Nerve Fiber Layer Thickness
Girkin CA; Fazio MA
American Journal of Ophthalmology 2018; 196: 154-164
78514 Oral Memantine for the Treatment of Glaucoma: Design and Results of 2 Randomized, Placebo-Controlled, Phase 3 Studies
Brandt JD; Johnson CA
Ophthalmology 2018; 125: 1874-1885
78939 Racial Differences in Rate of Change of Spectral-Domain Optical Coherence Tomography-Measured Minimum Rim Width and Retinal Nerve Fiber Layer Thickness
Liebmann JM
American Journal of Ophthalmology 2018; 196: 154-164
78514 Oral Memantine for the Treatment of Glaucoma: Design and Results of 2 Randomized, Placebo-Controlled, Phase 3 Studies
Zangwill LM
Ophthalmology 2018; 125: 1874-1885
78939 Racial Differences in Rate of Change of Spectral-Domain Optical Coherence Tomography-Measured Minimum Rim Width and Retinal Nerve Fiber Layer Thickness
Belghith A
American Journal of Ophthalmology 2018; 196: 154-164
78514 Oral Memantine for the Treatment of Glaucoma: Design and Results of 2 Randomized, Placebo-Controlled, Phase 3 Studies
Schneider S; Badger H; Bejanian M
Ophthalmology 2018; 125: 1874-1885
